Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

Liposarcoma Clinical Trial

Official title:

Inside Liposarcoma Clinical Trials: Patient Experiences Shared While Undergoing Clinical Trials

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06039046
• Other study ID #: 90761840
• Status: Not yet recruiting
• Start date: October 2024
• Est. completion date: October 2026

Study information

• Verified date: September 2023
• Source: Power Life Sciences Inc.
• Contact: Michael B Gill
• Phone: 4159004227
• Email: bask[@]withpower.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The study seeks to delve into the firsthand experiences of patients diagnosed with liposarcoma who partake in a separate clinical research featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.

By joining this clinical study, individuals have the unique opportunity to contribute to the betterment of future liposarcoma patients and play an active role in advancing medical research.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: October 2026
• Est. primary completion date: October 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient has self-identified as planning to enroll in a clinical research

• Patient has been diagnosed with liposarcoma

• Patient is a minimum of 18 years or older

Exclusion Criteria:

• Patient does not understand, sign, and return consent form

• Inability to perform regular electronic reporting

• Patient is pregnant

Related Conditions & MeSH terms

• Liposarcoma

Locations

Country	Name	City	State
United States	Power Life Sciences	San Francisco	California

Sponsors (1)

Lead Sponsor	Collaborator
Power Life Sciences Inc.

Country where clinical trial is conducted

United States, 

References & Publications (3)

Chen M, Yang J, Zhu L, Zhou C, Zhao H. Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases. J Cardiothorac Surg. 2014 Jul 4;9:119. doi: 10.1186/1749-8090-9-119. — View Citation

Marino-Enriquez A, Hornick JL, Dal Cin P, Cibas ES, Qian X. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration. Cancer Cytopathol. 2014 Feb;122(2):128-37. doi: 10.1002/cncy.21362. Epub 2013 Nov 12. — View Citation

Rossouw DJ, Cinti S, Dickersin GR. Liposarcoma. An ultrastructural study of 15 cases. Am J Clin Pathol. 1986 Jun;85(6):649-67. doi: 10.1093/ajcp/85.6.649. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients who decide to participate in a liposarcoma clinical study		3 months
Primary	Rate of patients who remain in liposarcoma clinical study to trial completion		12 months